Valuation (62%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 15.75 | N/A |
| PEG Ratio (TTM) | -0.46 | N/A |
| P/S Ratio (TTM) | 0.43 | N/A |
| P/B Ratio (TTM) | 0.90 | N/A |
| P/FCF Ratio (TTM) | 2.51 | N/A |
| Price to 5YR AVG Earnings Ratio | -17.46 | N/A |
| Price to 5YR AVG FCF Ratio | 8.11 | N/A |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.76% | N/A |
| ROE (TTM) | 5.54% | N/A |
| Net Profit Margin (TTM) | 2.74% | N/A |
| ROIC 5YR AVG | 18.79% | N/A |
Growth (52%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 418.78% | -140.50% | 1.57% |
| Revenue | 1.41% | -0.89% | 1.38% |
| Net Income | 432.54% | -138.98% | 8.15% |
| Cash Flow | 219.20% | 16.29% | 6,059.12% |
Health (56%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.83 | N/A |
| Quick Ratio (TTM) | 1.00 | N/A |
| D/E Ratio (TTM) | 0.02 | N/A |
| Interest Coverage (TTM) | 3.30 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 2.09 | N/A |
| LTL to 5YR AVG FCF | 2.79 | N/A |
| Shares Outstanding Growth 5YR AVG | 1.89% | N/A |